The U.S. Food and Drug Administration said it is hiring more than 1,000 employees and launched a pilot communications program meant to speed sponsor‑agency exchanges. The hiring push includes reviewers and inspectors, while the new pilot allows drug sponsors to email quick clarifications to Office of New Drugs staff with a three‑business‑day response target. FDA Commissioner Marty Makary framed the changes as reducing review uncertainty and cutting sponsor wait times. The moves come amid industry concerns about review delays and recent staff departures; biopharma companies have signaled the need for more predictable regulatory interactions.